Full image

Beijing Cancer Hospital, Beijing, China

  • ESTD:1958
  • No. of beds790
Book Appointment

About Hospital

Peking University Cancer Hospital (three other titles — Beijing Cancer Hospital, Beijing Institute for Cancer Research, and Peking University School of Oncology — refer to the same entity) ranks among the China’s top academic cancer centers. Its physicians provide the highest quality of health care throughout the hospital and its faculty members responsible for translational research are respected for their dedication to teaching and training.

Peking University Cancer Hospital physicians provide patient-oriented medical services in a wide variety of cancer specialties treating gastric cancer, breast cancer, lung cancer, colorectal cancer, liver cancer, esophageal carcinoma, lymphoma, melanoma, and much more. Our team consists of a group of experts from different disciplines including oncology (cancer medicine), surgeons, radiology, and pathology.

At Peking University Cancer Hospital, research into the basic oncologic process and clinical investigation on specific cancer diseases go hand in hand. Investigations into cancer epidemiology, etiology, genetics, oncogenesis, pathogenesis and experimental therapeutics and many other fields keep Peking University Cancer Hospital at the forefront of biomedical research, driving the discoveries that lead to new ways to prevent and treat cancer.

Team and Specialities

Medical Oncology

Surgical Oncology

Chemotherapy

Immunotherapy

Radiotherapy

Bone Marrow Transplant

Car T Cell Therapy

Infrastructure

Beijing Cancer Hospital is one of the famous large special hospitals in the field of cancer research and treatment in China. It has 790 hospital beds, 26 clinical departments and 13 medical technological departments.

For the past many years, our hospital has been engaged in the diagnosis and treatment of various tumors, such as breast cancer, lung cancer, colorectal cancer, liver cancer, gastric cancer, esophageal carcinoma, malignant lymphoma, gynecological cancer, tumor of head and neck, tumor of urological system, bone tumor and melanoma. The hospital advocates the cooperation of multiple disciplines, integrate medical sources of all departments, and has established different cooperation groups for mono-disease including breast cancer, gastric cancer, lymphoma, and liver cancer, providing normalized and individualized combined treatment for the patients.

The hospital is a member of the national base for clinical pharmacology. From 2000 to 2007, our hospital has completed 76 clinical trials, of which 52 belonged to domestic clinical trials, 10 belonged to international multi-center clinical trials, and 14 belonged to clinical trials for medical equipment. There are 35 on-going programs of domestic clinical trials, 11 international multi-center clinical trials, and 4 clinical trials for medical equipment.

The breast cancer patients treated with conservative surgery in the Breast Cancer Center of the hospital have reached 51%. The Department of Gastrointestinal Surgery has developed multimodality therapy for gastric cancer and neo-adjunctive radiochemical therapy for rectal cancer. The Department of Hepatic, Biliary & Pancreatic Surgery has performed various kinds of hepatic and pancreatic operations with high difficulty, and advocated the multimodality therapy for liver metastasis of colon carcinoma. The Department of Thoracic Surgery has developed bisaxillary lymphnode dissection for carcinoma of gastric cardia, high level cervical excision of esophageal carcinoma, complex surgery of lung cancer such as plasty of pulmonary artery, and chest minimally invasive surgery. The Department of Respiratery Oncology has established the normalized chemotherapy regimens for lung cancer of advanced stage, making that the median survival and yearly survival rate of NSCLC and SCLC reach or approach the international level, respectively. The Department of Gastrointestinal Oncology has been engaged in promoting the normalized chemotherapy for gastric cancer and colorectal cancer. The Department of lymphoma & Hematologic Oncology has been walking in the front row in China in the field of diagnosis and treatment of malignant lymphoma. The Department of Renal Cancer & Melanoma has treated patients by bio-immunotherapy, and makes a remarkable achievement. The Department of Radiotherapy has treated malignant tumors by dynamic intensity modulated radiation therapy (DIMRT), concomitant chemo-radiotherapy, clinical application of radiosensitizer, and gene therapy combined with radiotherapy and hyperthermia therapy. The Department of Integrated Traditional Chinese and Western Medicine has alleviated the pain of patients maximally under the premise of effective control of tumor, and established the agreement prescriptions to relieve side effects of chemotherapy. The PACS/RIS system in the Department of Medical Imaging has developed studies on diagnosis, staging, evaluation and prediction of efficacy by combination of various kinds of imaging methods. The Department of Ultrasound has developed ultrasound-guided radiofrequency ablation to treat liver cancer, increasing the diagnosis rate and differential diagnosis rate. The hospice is one of the service agencies for cancer patients established in 20 key hospitals national wide by “The Li Ka Shing Foundation National Hospice Service Programme”, which provides free drop-in medical services and analgesic drugs for patients with advanced cancer to improve their quality of life.

Location

It’s about 18km from Beijing Capital International Airport to the City Center. There are 3 ways for you to get to the city center from the airport.

1) Airport Express Railway

The airport express has 4 stops: Dongzhimen (Station transfer for Line 2 and 13), Sanyuanqiao (station transfer for line 10), T2 and T3.
Time: T2: 06:35-23:10
T3:06:20-22:50
Dongzhimen: 06:00-22:30,
Interval: 10 Mins/shift
Pick-up point: NO.2 parking lot of T2 (2GF)
NO.3 parking lot of T3 (2GF)
Ticket Price: RMB 25
Station Transfer Reminder: Sanyuanqiao Station connects to Subway Line 10.
Dongzhimen Station connects to Subway Line 2 and Subway Line 13.

2) Taxi

Pick-up point: Taxis are available in all arrival areas.
T1: outer lane outside NO.1 Gate (1F)
T2: middle lane outside NO.5-9 Gate (1F)
T3: please refer to the instructions
Price:
Flag-down Rate: RMB 13 for the first 3km (2mi)
Unit Fare: 1. RMB 2.3/km over 3km in the daytime
2. RMB2.76/km from 23:00 to 05:00 the next day
Low-Speed Drive and Waiting Fare: Extra RMB 4.6 for each 5mins’ waiting or driving with the speed of lower than 12km/h during rush hours. RMB 2.3 during other time.
Empty-run Fee: RMB 3.45/km for the extra distance beyond 15km (9mi)
During off peak hours, that is, but very hard in rush hours periods 07:00 – 09:00 & 17:00 – 20:00 due to heavy demand and terrible traffic jam. Beijing taxis are available day and night, and each car holds normally four adult passengers.

Hospital Address

Beijing Cancer Hospital

52 Fucheng Rd, Wu Ke Song, Haidian District, Beijing, China

Facilities

There are 301 doctors including 52 full professors and 84 associated professors specialized in treating various types and stages of cancers. With 790 beds, 28 clinical departments, 13 paramedical departments, and totally 24 wards, Peking University Cancer Hospital is a renowned cancer center in China devoted exclusively to cancer care, cancer education, and cancer research and cancer prevention.

Hospital Video

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

×
Start chat
Need help with cancer treatment?
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy